Loading...

Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features

PURPOSE: To investigate dexamethasone intravitreal implant 0.7 mg (DEX implant) for the treatment of diabetic macular oedema (DME) refractory to anti-vascular endothelial growth factor (anti-VEGF) therapy and evaluate predictive factors. METHODS: Two-centre retrospective interventional case series,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ophthalmologica
Main Authors: Hatz, Katja, Ebneter, Andreas, Tuerksever, Cengiz, Pruente, Christian, Zinkernagel, Martin
Format: Artigo
Sprog:Inglês
Udgivet: S. Karger AG 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6008872/
https://ncbi.nlm.nih.gov/pubmed/29402873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000485852
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!